Studies on the interaction of obesity and COVID-19 continue; it is hypothesized that patients with obesity have impaired immune responses and abnormal secretion of proinflammatory cytokines such as interleukin 6 (IL-6), which are already present due to COVID-19, worsening the disease. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.